[1] [1] W. R. Chen, R. L. Adams, R. Carubelli, R. E. Nordquist, "Laser-photosensitizer assisted immunotherapy: A novel modality in cancer treatment," Cancer Lett. 115, 25–30 (1997).

[2] [2] W. R. Chen, W. G. Zhu, J. R. Dynlacht, H. Liu, R. E. Nordquist, "Long-term tumor resistance induced by laser photo-immunotherapy," Int. J. Cancer 81, 808–812 (1999).

[3] [3] W. R. Chen, R. L. Adams, S. Heaton, D. T. Dickey, K. E. Bartels, R. E. Nordquist, "Chromophoreenhanced laser-tumor tissue photothermal interaction using 808 nm diode laser," Cancer Lett. 88, 15–19 (1995).

[4] [4] W. R. Chen, R. Carubelli, H. Liu, R. E. Nordquist, "Laser immunotherapy: A novel treatment modality for metastatic tumors," Mol. Biotechnol. 25, 37–43 (2003).

[5] [5] S. Song, F. Zhou, R. E. Nordquist, R. Carubelli, H. Liu, W. R. Chen, "Glycated chitosan as a new nontoxic immunological stimulant," Immunopharmacol. Immunotoxicol. 31, 202–208 (2009).

[6] [6] F. Zhou, S. Song, W. R. Chen, D. Xing, "Immunostimulatory properties of glycated chitosan," J. X-Ray Sci. Tech. 19, 285–292 (2011).

[7] [7] W. R. Chen, A. K. Singhal, H. Liu, R. E. Nordquist, "Laser immunotherapy induced antitumor immunity and its adoptive transfer," Cancer Res. 61, 459–461 (2001).

[8] [8] W. R. Chen, H. Liu, J. W. Ritchey, K. E. Bartels, M. D. Lucroy, R. E. Nordquist, "Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats," Cancer Res. 62, 4295– 4299 (2002).

[9] [9] M. F. Naylor, W. R. Chen, T. K. Teague, L. Perry, R. E. Nordquist, "In situ photo immunotherapy: A tumor-directed treatment modality for melanoma," Br. J. Dermatol. 155, 1287–1292 (2006).

[10] [10] X. Li, M. F. Naylor, H. Le et al., "Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: A preliminary study," Cancer Biol Ther. 10(11), 1081–1087 (2010).

[11] [11] X. Li, G. L. Ferrel, M. C. Guerra et al., "Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients," Photochem. Photobiol. Sci. 10, 817–821 (2011).

[12] [12] L. J. Anghileri, J. Robert, Hyperthermia in Cancer Treatment, CRC Press, Boca Raton, FL (1986).

[13] [13] F. Zhou, D. Xing, Z. Ou, B. Wu, D. E. Resasco, W. R. Chen, "Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes," J. Biomed. Opt. 14, 021009 (2009).

[14] [14] R. C. Myers, B. H. Lau, D. Y. Kunihira, R. R. Torrey, J. L. Woolley, J. Tosk, "Modulation of hematoporphyrin derivative-sensitized phototherapy with Corynebacterium parvum in murine transitional cell carcinoma," Urology 33, 230–235 (1989).

[15] [15] Y. H. Cho, R. C. Straight, J. A. Smith Jr, "Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model," J. Urol. 147, 743–746 (1992).

[16] [16] G. Krosl, M. Korbelik, "Potentiation of photodynamic therapy by immunotherapy: The effect of schizophyllan (SPG)," Cancer Lett. 84, 43–50 (1994).

[17] [17] M. Korbelik, V. R. Naraparaju, N. Yamamoto, "Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer," Br. J. Cancer 75, 202–207 (1997).

[18] [18] P. Correale, M. G. Cusi, K. Y. Tsang et al., "Chemoimmunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte-macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients," J. Clin. Oncol. 23, 8950– 8958 (2005).

[19] [19] J. O. Armitage, "Emerging application of recombinant human granulocyte-macrophage colony-stimulating factor," Blood 92, 4491–4508 (1998).

[20] [20] L. Cruz-Merino, E. Grande-Pulido, A. Albero- Tamarit, M. E. C. M. Viliena, "Cancer and immune response: Old and new evidence for future challenges," Oncologist 12, 1246–1254 (2008).